Biotech news from around the world

IF 33.1 1区 生物学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
{"title":"Biotech news from around the world","authors":"","doi":"10.1038/s41587-025-02643-7","DOIUrl":null,"url":null,"abstract":"<p>Amgen invests $200 million in a new technology center in southern India and plans to invest further in the future to strengthen its operations and R&amp;D capabilities. The site in Hyderabad currently employs 300 people, with plans for 1,700 more recruits skilled in data analytics, AI and digital health technologies.</p><p>The Canadian government cancels a deal with US-based Novavax to buy millions of doses of a COVID-19 vaccine that was to be made in a new biologics manufacturing facility in Montreal. It would have been the first to be produced in Canada. Novavax says the cause is the company not receiving regulatory approval by the end of 2024 for its COVID-19 vaccine using bulk antigen produced at the facility.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"61 1","pages":""},"PeriodicalIF":33.1000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41587-025-02643-7","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Amgen invests $200 million in a new technology center in southern India and plans to invest further in the future to strengthen its operations and R&D capabilities. The site in Hyderabad currently employs 300 people, with plans for 1,700 more recruits skilled in data analytics, AI and digital health technologies.

The Canadian government cancels a deal with US-based Novavax to buy millions of doses of a COVID-19 vaccine that was to be made in a new biologics manufacturing facility in Montreal. It would have been the first to be produced in Canada. Novavax says the cause is the company not receiving regulatory approval by the end of 2024 for its COVID-19 vaccine using bulk antigen produced at the facility.

全球生物技术新闻
安进公司投资 2 亿美元在印度南部新建了一个技术中心,并计划在未来进一步投资,以加强其运营和研发能力。加拿大政府取消了与美国诺维信公司(Novavax)达成的购买数百万剂 COVID-19 疫苗的协议。这将是加拿大生产的第一批疫苗。Novavax 称,原因是该公司使用该工厂生产的批量抗原生产的 COVID-19 疫苗未能在 2024 年底前获得监管部门的批准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature biotechnology
Nature biotechnology 工程技术-生物工程与应用微生物
CiteScore
63.00
自引率
1.70%
发文量
382
审稿时长
3 months
期刊介绍: Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research. The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field. Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology. In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信